Product
Active topical NS2 1% dermatologic cream
1 clinical trial
1 indication
Indication
Sjogren-Larsson SyndromeClinical trial
Phase II Study of the Safety, Pharmacokinetics, and Exploratory Activity of Once Daily (QD) Topical Application of NS2 Cream to Treat Ichthyosis in Subjects With Sjögren-Larsson Syndrome (SLS)Status: Completed, Estimated PCD: 2016-05-01